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Abstract. - The aim of our study was to analyze the influence of different surgical techniques (left atriotomy, right atriotomy, 
biatrial approach and tumor basis solving) on early and late outcomes of patients operated on for cardiac myxoma. We 
evaluated 74 patients operated on for cardiac myxoma from 1982 through 2011. Sixty-six patients (89.19%) had left atrial 
myxoma and 8 (10.81%) right atrial myxoma. Histopathologic examination confirmed the diagnosis of atrial myxoma in 
all patients. In analyzing different surgical techniques we found that they had no influence on the duration of extracorpo-
real circulation and aortic cross-clamp time. Mortality analysis revealed: no intraoperative mortality; early mortality in 2 
patients; late mortality in 12 patients. Survival after 29 years was 81.08%. There were no myxoma recurrences. 83.78% of 
the patients had functional improvement. In our opinion the best approach for right atrial myxoma is through right atri-
otomy, for left atrial myxoma through left atriotomy, with a biatrial approach for large tumors of the left atrium or when 
exploration of all 4 chambers is necessary. Subendocardial excision or thermocauterization was used for small tumors 
with bases less than 5 mm. Myxoma with a wider basis, depending on the localization, were partially resected at the atrial 
septum in the whole thickness or subendocardial excision of the tumor basis.
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INTRODUCTION
Primary tumors of the heart are exceedingly rare, 
accounting  for  0.002-0.03%  of  all  tumors  (Ipek, 
2005). The vast majority of primary cardiac tumors 
are benign and the most common type in adults is 
myxoma with an estimated incidence of 0.5 per mil-
lion of the population per year (MacGowan, 1993). 
Approximately 75% of all myxomas are located in the 
left atrium (Bhan 1998). Most of them arise from a 
short stalk in the atrial septum. The symptoms are 
atypical and diagnosis was difficult to establish un-
til the development of two dimensional echocardi-
ography. Although biologically benign, due to their 
localization myxomas are considered “functionally 
malignant” tumors. Diagnosis of cardiac myxoma is 
an indication for surgical treatment.
MATERIALS AND METHODS
From January 1982 to January 2011, 80 patients 
at the Clinic for Cardiac Surgery, Clinical Center 
of Serbia, Belgrade, were operated on for cardiac 
myxomas. Seventy four patients were included in 
the study, while 6 patients were lost for follow-up 
as  they  moved  abroad  or  changed  their  address. 
Twenty-four patients (32.45%) were male and 50 
(67.55%) female. The median age was 46.7±15.28 2 A. MIKIĆ   ET AL.
(range 4 to 75 years); 75% of the patients were in 
the age interval between 40 and 60. Sixty-six pa-
tients (89.19%) had left atrial myxoma and 8 pa-
tients (10.81%) had right atrial myxoma. None of 
them had a family history of myxoma, or multiple 
myxomas.
The clinical profile and symptoms of the patients 
are summarized in Table 1.
Symptoms were present 2 to 36 months (mean 
13.60±7.52  months)  before  the  operation.  At  the 
time of diagnosis, 3 patients (4.05%) were asymp-
tomatic. In the NYHA class III and IV there were 
45 patients (60.8%). The most common symptoms 
were fatigue in 61 patients (82.43%) and symptoms 
of valve obstructions in 55 patients (74.32%). Preop-
erative embolic events were present in 15 patients 
(9  cerebral,  4  pulmonary,  2  peripheral).  Physical 
examination was suggestive for mitral stenosis in 
42 patients (56.75%), mitral regurgitation in 13 pa-
tients (17.56%) and tricuspid stenosis in 3 patients 
(4.10%).
Preoperative  diagnosis,  after  standard  clinical 
examination, was established in all patients by tran-
sthoracic echocardiography. In 15 patients (20.27%) 
a transoesophageal echocardiography was also nec-
essary (in 10 patients left atrial thrombosis was sus-
pected and in 5 patients a better visualization of the 
localization of the tumor basis was needed). Selective 
coronary arteriography was performed in 4 patients 
(5.45%) with a history of chest pain.
The patients underwent operations soon after the 
diagnosis of myxoma (1-8 days, mean 3.14 ± 1.5 
days). Two patients had urgent procedures due to se-
vere symptoms.
Table 1. Preoperative clinical manifestations in patients with cardiac myxomas
Clinical semiology Number of patients  (%)
General symptoms and signs 68 91.89 
fatigue 61 82.43 
elevated sedimentation rate  32 43.24 
anemia 10 13.51  
fever 6 8.10 
weight loss 5 6.76 
Heart symptoms and signs 59 79.73 
symptoms of valve obstruction 55 74.32 
cardiomegaly 52 70.27 
syncope 6 8.11
angina pectoris 4 5.41
NYHA classification 
NYHA I 3 4.1
NYHA II 26 35.1
NYHA III 31 41.9
NYHA IV 14 18.9
Heart rhythm 
sinus rhythm 67 90.54 
atrial fibrillation  7 9.46 
bundle branch block  5 6.76 
Embolic events 15 20.27
cerebral 9 12.17
pulmonary 4 5.41 
peripheral 2 2.7 
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The  standard  surgical  procedure  was  used: 
medial sternotomy, total cardiopulmonary bypass, 
moderate  hypothermia  (32°C-34°C)  and  cardiac 
arrest  using  crystalloid  cardioplegia.  The  mean 
time of extracorporeal circulation was 57.97 min, 
61.60 min, and 64.60 min for left atriotomy, right 
atriotomy and biatrial approach, respectively. The 
mean aortic cross-clamp time was 42.85 min (41.90 
min, 42.40 min and 46.00 min for left atriotomy, 
right atriotomy and biatrial approach, respective-
ly). In 8 patients with right atrial myxoma we used 
right atriotomy (10.81%). In 66 patients with left 
atrial myxoma we used a left atrium approach in 
53 (71.62%) and a biatrial approach in 13 patients 
(17.56%). According to the local finding of the tu-
mor basis, in 34 patients (45.94%) the tumor was 
resected together with a partial resection of the atri-
al septum in the whole thickness 4-5 mm from the 
edge of the tumor basis. Sixteen of these patients 
had direct suture of the interatrial septum, and in 
18 patients the interatrial septum was reconstructed 
using a patch (Dacron patch in 4 patients and peri-
cardium in 14 patients). Sixteen patients (21.62%) 
underwent complete excision of the tumor with a 
subendocardial excision of the tumor and endocar-
dial suture. In 24 patients (32.43%) we used ther-
mocauterization of the tumor basis. Five patients 
had associated procedures: 2 patients needed cor-
onary artery grafting (one to the left anterior de-
scending coronary artery and the other to the right 
coronary artery); 1 patient underwent mitral valve 
replacement,  and  2  patients  mitral  valvuloplasty. 
Histopathologic examination of the resected speci-
men confirmed the diagnosis of atrial myxoma in 
all the patients. 
All the patients were followed up on an outpa-
tient basis 1, 3, 6, 12 months after discharge and then 
at yearly intervals. The mean follow-up was (12.2 ± 
1.6) years. Follow-up included clinical examination, 
electrocardiography and echocardiography.
Statistical analysis was performed using the χ2 
test, Fischer′s test, Wilcoxon’s test and Spearman’s 
test. Survival rates were calculated using the Kap-
lan-Meier method (Castells, 1993).
RESULTS
Two patients (2.7%) died postoperatively. The first 
died on the third day due to cerebral coma and the 
second on the seventh day due to hepatorenal insuf-
ficiency.
Analyzing the different surgical techniques, we 
found that they had no influence on the duration of 
extracorporeal  circulation  and  aortic  cross-clamp 
time (p>0.05). During the follow-up period 37 pa-
tients (51.39%) were in NYHA class I, 30 (41.67%) in 
NYHA class II and 5 (6.94%) in NYHA class III. Ten 
patients remained in the same NYHA class, and none 
of them had a worsening of functional class. 83.78% 
of the patients had functional improvement.
In  the  preoperative  period,  12  patients  had 
rhythm  disturbances  or  conduction  disorders  (7 
atrial fibrillation, 3 incomplete right bundle branch 
block, 1 complete left bundle branch block and 1 
complete right bundle branch block). These patients 
had no changes in the perioperative and follow-up 
period, but 4 other patients (5.5%) had new arrhyth-
mias: 3 of them developed atrial fibrillation, 1 pa-
tient had incomplete right bundle branch block. In 
1 patient who developed complete atrioventricular 
block one year after the operation, implantation of 
a permanent pace maker was performed. Statistical 
analysis did not reveal an effect of the different surgi-
cal approaches in solving the tumor basis and on the 
development of heart arrhythmias (p > 0.05).
During late follow-up, 3 patients required addi-
tional cardiac surgical procedure after the extirpa-
tion of myxoma: 1 patient had mitral valve replace-
ment after 4 years, in 1 patient mitral valvuloplasty 
was performed after 6 years, and 1 patient under-
went aortic valve replacement 5 years after the first 
operation.
One patient had thromboembolic event, i.e. cer-
ebral emboli with a transient ischemic attack 5 years 
after the operation. This patient had atrial fibrilla-
tion. A control echocardiography did not show any 
signs of myxoma.4 A. MIKIĆ   ET AL.
Mortality analysis revealed: a) no intraoperative 
mortality; b) early mortality in 2 patients (cerebral 
coma and hepatorenal insufficiency); c) late mortal-
ity in 12 patients. Survival after 29 years was 81.08%. 
(Fig. 1).
There were no myxoma recurrences in the oper-
ated patients.
DISCUSSION
Cardiac myxomas are the most frequent benign tu-
mors of the heart which can be localized in any of 
the four cardiac chambers. Approximately 75% of all 
myxomas are located in the left atrium. Our study 
comprised 74 patients, predominantly females that 
were operated on for cardiac myxomas. The major-
ity of patients (75%) were aged between 40 and 60 
years. These demographic data are in concordance 
with the data from literature (Keeling, 2002, Kar-
lof, 2006). Until now, large studies of patients with 
myxoma have been published by: Murphy et al. - 63 
patients over a period of 25 years (Murphy, 1990), 
Miralles et al. - 58 patients for a period of 17 years 
(Miralles, 1991), Bortolotti et al. - 54 patients for a 
period of 20 years (Bortolotti, 1990) and Bjessmo et 
al. - 63 patients for a period of 40 years (Bjessmo, 
1997).
Preoperative  diagnosis  was  established  by 
echocardiography in all patients. The development 
of echocardiography enabled earlier diagnosis, pos-
sibly before the symptoms became pronounced. De-
laying the operation carries the risk of pulmonary or 
systemic embolization or local obstruction, as it is 
known that they grow fairly rapidly (Kusano, 2002; 
Malekzadeh, 1989). In our study we had 15 embo-
lic events (20%). Bortollotti had a few more embolic 
events (25%). In his study an embolic event was the 
first symptom in 10 of 13 patients. This is why car-
diac myxoma is an indication for urgent surgery, es-
pecially in patients with severe dyspnea or high risk 
of embolization (Reynen 2005).
There are some dilemmas in the literature about 
the  local  surgical  approach  to  myxoma  (Stevens, 
2005). We used right atriotomy in order to approach 
myxomas located in the right atrium. In 66 patients 
Years after surgery
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with left atrial myxomas, a left atriotomy approach 
was performed in 53 patients and a biatrial approach 
in 13 patients. Our opinion is that the best approach 
for right atrial myxoma is through right atriotomy, 
and for left atrial myxoma through left atriotomy. 
The biatrial approach was used for large tumors of 
the left atrium or when exploration of all 4 chambers 
was necessary.
Another important problem in the surgical treat-
ment of atrial myxoma is solving the tumor basis in 
order to prevent tumor recurrence. Subendocardial 
excision  or  thermocauterization  were  used  in  pa-
tients who had small tumor basis, less than 5mm, 
attached  to  the  endocardium.  Numerous  authors 
(Schaff, 2000; Selkane, 2003) prefer septum excision 
with reconstruction or sutura compared to thermal 
or laser coagulation of the tumor basis in myxomas 
attached to the interatrial septum. There is general 
agreement that the site of the attachment should be 
resected with a clear margin, even if this involves 
the artificial creation of an atrial septal defect that 
needs to be closed by a pericardial patch. Using dif-
ferent surgical techniques we found no difference in 
the duration of the operation and the development of 
new arrhythmias.
The vast majority of patients (83.78%) had func-
tional improvement, and none had worsening after 
the operation. Our patients had early mortality and 
long-term  survival  similar  to  studies  published  in 
literature (Bjessmo, 1997; Bortolotti, 1990; Keeling, 
2002; Miralles, 1991).
It has been estimated that cardiac myxomas re-
cur with an approximate incidence of 7%. Inadequate 
primary excision, tumor seeding at the time of op-
eration, and multiple foci of tumor have all been pro-
posed as explanations for recurrence. Recurrence of 
sporadic cardiac myxomas after removal has been 
reported as well as in cases of multifocal tumors and 
in cases with a family history of the tumor. This is the 
reason for routine echocardiography control. In our 
series there were no recurrences during the follow-
up period, indirectly suggesting that all surgical ap-
proaches were successful.
CONCLUSION
All patients in our series of 74 operated on for car-
diac myxoma had improvement after the operation 
and there were no recurrences. Our opinion is that 
the best approach for right atrial myxoma is through 
right atriotomy, and for left atrial myxoma through 
left atriotomy. A biatrial approach was used in pa-
tients with large tumors of the left atrium or when 
exploration of all 4 chambers was necessary. Another 
important matter is solving the tumor basis in order 
to prevent tumor recurrence. Subendocardial exci-
sion or thermocauterization were used in patients 
who had a small tumor basis of less than 5mm, at-
tached to the endocardium. In patients who had a 
wider tumor basis, the tumor was resected with par-
tial resection of the atrial septum in the whole thick-
ness, 4-5 mm from the edge of the tumor basis or by 
subendocardial excision of the basis. Our results are 
in agreement with those reported in literature, so we 
can recommend our approach as safe and beneficial.
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